From the bench to the pipeline : testing the immunosuppressive potential of novel therapy targeting Annexin A1
Autoimmune diseases and mood-related disorders are among the major plagues of our modern society, as they impair the normal daily life of patients at both social and physical levels. Autoimmunity is caused by the loss of immunological tolerance i.e. the inability of immune cells to make a distinctio...
| Main Author: | |
|---|---|
| Published: |
Queen Mary, University of London
2014
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.667294 |